 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/02/2025 |
$8.25 |
$8.33 |
$7.97 |
$8.00 |
67.20K | | 12/03/2025 |
$8.06 |
$8.57 |
$8.03 |
$8.41 |
81.90K | | 12/04/2025 |
$8.43 |
$8.85 |
$8.30 |
$8.80 |
46.70K | | 12/05/2025 |
$9.16 |
$9.18 |
$8.80 |
$8.94 |
71.70K | | 12/08/2025 |
$9.22 |
$9.69 |
$9.20 |
$9.61 |
94.10K |
|
|
| Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 is delivered in combination with granulocyte-macrophage colony-stimulating factor to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. | |
|
Greenwich LifeSciences (GLSI) has the following price history information. Looking back at GLSI historical stock prices for the last five trading days, on December 02, 2025, GLSI opened at $8.25, traded as high as $8.33 and as low as $7.97, and closed at $8.00. Trading volume was a total of 67.20K shares. On December 03, 2025, GLSI opened at $8.06, traded as high as $8.57 and as low as $8.03, and closed at $8.41. Trading volume was a total of 81.90K shares. On December 04, 2025, GLSI opened at $8.43, traded as high as $8.85 and as low as $8.30, and closed at $8.80. Trading volume was a total of 46.70K shares. On December 05, 2025, GLSI opened at $9.16, traded as high as $9.18 and as low as $8.80, and closed at $8.94. Trading volume was a total of 71.70K shares. On December 08, 2025, GLSI opened at $9.22, traded as high as $9.69 and as low as $9.20, and closed at $9.61. Trading volume was a total of 94.10K shares.
GLSI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Greenwich LifeSciences shares, starting with a $10,000 purchase of GLSI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/28/2020 |
|
| End date: |
12/08/2025 |
|
| Start price/share: |
$4.91 |
|
| End price/share: |
$9.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
95.72% |
|
| Average Annual Total Return: |
13.79% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$19,569.85 |
|
| Years: |
5.20 |
|
|
|
| Date |
Close |
| 12/02/2025 | $8.00 | | 12/03/2025 | $8.41 | | 12/04/2025 | $8.80 | | 12/05/2025 | $8.94 | | 12/08/2025 | $9.61 |
|
|
Free GLSI Email Alerts:
